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Editorials SwansonRobotic pulmonary lobectomy—The future and probably should
remain soScott J. Swanson, MDUsing robotic technology to perform pulmonary surgery is of
great current interest to the thoracic surgical community.1
With the advent of video-assisted thoracic surgery in the
early 1990s, we have provided major benefit to our patients
undergoing all types of surgical procedures from video-
assisted thoracoscopic surgery (VATS) pleural biopsy to
what is now becoming more routine, VATS lobectomy. No
question exists that increasing data have shown that perioper-
ative recovery, complication rates, quality of life, and cost to
the system all favor a VATS approach over an open approach
(thoracotomy) for pulmonary lobectomy. For the most im-
portant outcome variable, that of cancer-related survival,
the data have continued to suggest at least an equivalence
between VATS lobectomy and thoracotomy and lobectomy,
with a hint of improved survival using the VATS ap-
proach.2,3 In the Society of Thoracic Surgeons database,
VATS lobectomy has increased to more than 30% of all
lobectomies performed. This operation is now quite
standardized, with an approach to the hilar vessels,
bronchus, and lymph nodes similar to that of the open
approach. Training programs have incorporated this
operation into the standard armamentarium of the thoracic
resident, and simulations courses and fellowships are
available to help provide learning opportunities to surgeons
who are out in practice.
With this background, robotic lobectomies have been per-
formed on a limited basis, with the advocates suggesting that
the visualization and dissection are superior compared with
a VATS approach. Robotic technology does have a certain
appeal. The arms have a wrist-like movement and the mag-
nification and depth of field of the robotic camera are supe-
rior to the standard VATS camera. However, it is not clear
that these are significant advantages compared with VATS
in the realm of cancer surgery. They might be useful for car-
diac or urologic procedures; however, in thoracic arena,
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currently not helpful. Compared with a VATS approach,
the robotic incisions are the same size, the stapling instru-
ments are the same, and the removal of the specimen is the
same. The safety of VATS dissection of the vascular struc-
tures is excellent, with minimal reported problems after
more than 17 years of experience. The completeness of
lymph node dissection is complete with VATS and is not
better with the robot. Also, the surgical time and cost are
significantly less for VATS.
Perhaps rather than advocate for a robotic approach to
pulmonary lobectomy, which has only theoretical benefits
over VATS at this point, we should more widely disseminate
the proper VATS lobectomy technique to our trainees and
colleagues in practice so that more patients gain the advan-
tages of the minimally invasive approach. It might be that
certain features of robotic technology can be adapted to
the VATS approach such as the 7 degrees of freedom of
the surgical arm movement and the depth of field of the cam-
era, without needing to buy into the whole enterprise, thus
saving money and unneeded resource investment. Certain
investigators can continue to push the envelope to search
for methods to bring innovations to our patients, such as ro-
botic surgery, but most of us should continue to disseminate
and perfect the VATS technique.References
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